These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32730781)

  • 1. Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
    van den Hoogen B; Santoni A; Sciumé G; Bowie A; O'Farrelly C; O'Neill L; Anthonsen M; Pardali K; Young S; Bergthaler A; Manel N; Zahn R; Kikkert M; Snijder E; van Kuppeveld F; Fouchier R; Hiscott J
    Virus Res; 2020 Oct; 287():198094. PubMed ID: 32730781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.
    Mellors J; Tipton T; Longet S; Carroll M
    Front Immunol; 2020; 11():1450. PubMed ID: 32733480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents.
    Villas-Boas GR; Rescia VC; Paes MM; Lavorato SN; Magalhães-Filho MF; Cunha MS; Simões RDC; Lacerda RB; Freitas-Júnior RS; Ramos BHDS; Mapeli AM; Henriques MDST; Freitas WR; Lopes LAF; Oliveira LGR; Silva JGD; Silva-Filho SE; Silveira APSD; Leão KV; Matos MMS; Fernandes JS; Cuman RKN; Silva-Comar FMS; Comar JF; Brasileiro LDA; Santos JND; Oesterreich SA
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32906733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
    Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for retinoids in the treatment of COVID-19?
    Trasino SE
    Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1765-1767. PubMed ID: 32459003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research?
    Mol Cell; 2020 Jul; 79(1):9-10. PubMed ID: 32619472
    [No Abstract]   [Full Text] [Related]  

  • 8. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
    Saul S; Einav S
    ACS Infect Dis; 2020 Sep; 6(9):2304-2318. PubMed ID: 32687696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.
    Huang SW; Tai CH; Hsu YM; Cheng D; Hung SJ; Chai KM; Wang YF; Wang JR
    Biomed J; 2020 Aug; 43(4):375-387. PubMed ID: 32611537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hard Nanomaterials in Time of Viral Pandemics.
    Reina G; Peng S; Jacquemin L; Andrade AF; Bianco A
    ACS Nano; 2020 Aug; 14(8):9364-9388. PubMed ID: 32667191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction of Studies on Potential Drug Therapies for COVID-19: A Call for Reliability and Scientific Integrity.
    Guzman-Prado Y
    Am J Cardiol; 2020 Oct; 132():173. PubMed ID: 32713654
    [No Abstract]   [Full Text] [Related]  

  • 12. Host switching pathogens, infectious outbreaks and zoonosis: A Marie Skłodowska-Curie innovative training network (HONOURs).
    van der Hoek L; Verschoor E; Beer M; Höper D; Wernike K; Van Ranst M; Matthijnssens J; Maes P; Sastre P; Rueda P; Drexler JF; Barr J; Edwards T; Millner P; Vermeij P; de Groof A; Thiel V; Dijkman R; Suter-Riniker F; Leib S; Koller R; Ramette A; Engler O; Beuret C
    Virus Res; 2018 Sep; 257():120-124. PubMed ID: 30316331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Biology Aids the Research of New Anti-COVID-19 Drugs.
    Lu J; Liu X
    Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug targets for COVID-19 therapeutics: Ongoing global efforts.
    Saxena A
    J Biosci; 2020; 45(1):. PubMed ID: 32661214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Proteases for Treating COVID-19.
    Luan B; Huynh T; Cheng X; Lan G; Wang HR
    J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and SARS-CoV-2: points to consider to face this new pandemic.
    Prieto Pozo AA; Salvador Sagüez FLD
    Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
    Calligari P; Bobone S; Ricci G; Bocedi A
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Will COVID-19 Affect the Health Care Economy?
    Cutler D
    JAMA; 2020 Jun; 323(22):2237-2238. PubMed ID: 32515806
    [No Abstract]   [Full Text] [Related]  

  • 20. Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.
    Hassan STS
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.